7-Pyrrolidinyl- and 7-piperidinyl-5-aryl-pyrrolo[2,3-d]pyrimidines--potent inhibitors of the tyrosine kinase c-Src |
| |
| Authors: | Altmann E Missbach M Green J Susa M Wagenknecht H A Widler L |
| |
| Institution: | Novartis Pharma Research, Arthritis and Bone Metabolism Therapeutic Area, Basel, Switzerland. eva.altmann@pharma.novartis.com |
| |
| Abstract: | 7-Heterocyclyl-5-aryl-pyrrolo2,3-d]pyrimidines represent a new class of highly potent and selective inhibitors of the tyrosine kinase pp60(c-Src). |
| |
| Keywords: | |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ |
|
